TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Windlas Biotech Ltd. ( (IN:WINDLAS) ) just unveiled an announcement.
Windlas Biotech Ltd. announced its schedule for upcoming meetings with investors and analysts, which are set to take place in December 2025. These meetings, involving prominent research and fund houses such as Fidelity International and Laburnum Capital, indicate the company’s proactive approach in engaging with stakeholders and maintaining transparency. The discussions will be based on publicly available documents, reflecting the company’s commitment to compliance and open communication.
More about Windlas Biotech Ltd.
Windlas Biotech Ltd. operates in the pharmaceutical industry, focusing on the manufacturing and development of pharmaceutical formulations. The company is known for its production of generic drugs and has a significant presence in the Indian market.
Average Trading Volume: 2,826
Technical Sentiment Signal: Sell
Current Market Cap: 16.69B INR
Find detailed analytics on WINDLAS stock on TipRanks’ Stock Analysis page.